Trials / Completed
CompletedNCT00586898
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objective: To determine the response to rapid hormonal cycling in patients with non-castrate prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GnRH | leuprolide and goserelin are gonadotropin-releasing hormone analogues |
| DRUG | Ketoconazole | An imidazole antifungal agent. reduces adrenal and testicular androgen production in men |
| DRUG | Bicalutamide | A pure nonsteroidal antiandrogen |
| DRUG | Testosterone transdermal gel | an androgenic anabolic steroid |
| DRUG | Estrogen transdermal patch | Estradiol is the primary and most potent estrogen |
Timeline
- Start date
- 2001-07-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-01-07
- Last updated
- 2016-03-25
- Results posted
- 2016-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00586898. Inclusion in this directory is not an endorsement.